Insider trade

Standard Biotools (LAB)Officer sold ~$13K

Sean Mackay, Officer at Standard Biotools, sold ~$13K of Standard Biotools shares.

~$13K
Approx. value · 13K sh @ $1.00
856K
Holds after · shares reported
Traded
May 22, 2025
Filed
May 23, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. May 21, 2025Insider · 3 peopleInsiders: 3 sales (~$20K)
  2. May 22, 2025 · this disclosureInsiderOfficer sold ~$13K of LAB shares in the open market

What came next

  1. May 22, 2025Insider · 2 peopleInsiders: 2 sales (~$6K)
  2. May 23, 2025Insider · 3 peopleInsiders: 3 sales (~$19K)
  3. Aug 13, 2025InsiderDirector purchased ~$98K of LAB shares in the open market
  4. Aug 14, 2025InsiderDirector purchased ~$162K of LAB shares in the open market
  5. Aug 15, 2025InsiderDirector purchased ~$183K of LAB shares in the open market
  6. Aug 22, 2025InsiderDirector purchased ~$253K of LAB shares in the open market
  7. Aug 25, 2025InsiderDirector purchased ~$248K of LAB shares in the open market
  8. Aug 26, 2025InsiderDirector purchased ~$158K of LAB shares in the open market
  9. Sep 3, 2025Insider · 10 days before an 8-KDirector purchased ~$316K of LAB shares in the open market
  10. Sep 4, 2025Insider · 9 days before an 8-KDirector purchased ~$319K of LAB shares in the open market
  11. Sep 9, 2025Insider · 4 days before an 8-KDirector purchased ~$129K of LAB shares in the open market
  12. Sep 13, 2025Company filing · Form 8-K · RestructuringAnnounced job cuts, closures or a restructuring“On September 13, 2025, Standard BioTools Inc. (the “Company”) commenced a restructuring plan, including a reduction-in-force of approximately 15% of its total global workforce.”
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Standard Biotools

For Standard Biotools, OQRO holds 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its LAB page.

Other recent filings by Sean Mackay, SVP & Chief Business Officer

The full history of Sean Mackay, SVP & Chief Business Officer is on the profile page.

How this filing works

Other disclosures at Standard Biotools

Everything OQRO holds on this company is on its LAB page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data